Search Results - "Sánchez–Tapias, José M."

Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients by Sánchez-Tapias, José M., Costa, Josep, Mas, Antoni, Bruguera, Miquel, Rodés, Juan

“…Background & Aims: The aim of this study was to investigate if the variable outcome of chronic hepatitis B may be related to hepatitis B virus (HBV) genotype…”
Get full text

Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure by Bonacci, Martín, Lens, Sabela, Mariño, Zoe, Londoño, María-Carlota, Rodriguez-Tajes, Sergio, Sánchez-Tapias, José M., Ramos-Casals, Manel, Hernández-Rodríguez, José, Forns, Xavier

“…Patients with hepatitis C virus–associated cryoglobulinemic vasculitis (HCV-CV) have high rates of clinical remission after treatment with direct-acting…”
Get full text

Development and validation of two models for early prediction of response to therapy in genotype 1 chronic hepatitis C by MARTINEZ-BAUER, Eva, CRESPO, Javier, ROMERO-GOMEZ, Manuel, MORENO-OTERO, Ricardo, SOLA, Ricard, TESEI, Nancy, PONS, Fernando, FORNS, Xavier, SANCHEZ-TAPIAS, José M

“…Early prediction of response to therapy in genotype 1 chronic hepatitis C is difficult. Two predictive models, a pretreatment scoring model (PreT-SM) and a…”
Get full text

Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy by Dlouhy, Ivan, Torrente, Miguel Á., Lens, Sabela, Rovira, Jordina, Magnano, Laura, Giné, Eva, Delgado, Julio, Balagué, Olga, Martínez, Antonio, Campo, Elías, Forns, Xavier, Sánchez-Tapias, José M., López-Guillermo, Armando

“…Diffuse large B cell lymphoma (DLBCL) patients carrying hepatitis C virus (HCV) have higher risk of treatment toxicity and complications. The aim of this study…”
Get full text

Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C by Puig-Basagoiti, Francesc, Forns, Xavier, Furcic, Ivana, Ampurdanes, Sergi, Gimenez-Barcons, Mireia, Franco, Sandra, Sanchez-Tapias, Jose M, Saiz, Juan-Carlos

“…Liver Unit, Institut de Malalties Digestives, Departament de Medicina (IMD), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital…”
Get full text

Peginterferon-Alfa2a Plus Ribavirin for 48 Versus 72 Weeks in Patients With Detectable Hepatitis C Virus RNA at Week 4 of Treatment by Sánchez–Tapias, José M., Diago, Moisés, Escartín, Pedro, Enríquez, Jaime, Romero–Gómez, Manuel, Bárcena, Rafael, Crespo, Javier, Andrade, Raúl, Martínez–Bauer, Eva, Pérez, Ramón, Testillano, Milagros, Planas, Ramón, Solá, Ricard, García–Bengoechea, Manuel, Garcia–Samaniego, Javier, Muñoz–Sánchez, Miguel, Moreno–Otero, Ricardo

“…Background & Aims: Patients with chronic hepatitis C who do not respond rapidly to therapy have a low chance of developing a sustained virologic response (SVR)…”
Get full text

Nosocomial acquisition of the hepatitis C virus by Forns, Xavier, Sánchez-Tapias, Jose M, Bruguera, Miquel

Get full text

Life-Threatening Cryoglobulinemia: Clinical and Immunological Characterization of 29 Cases by Ramos-Casals, Manuel, Robles, Angel, Brito-Zerón, Pilar, Nardi, Norma, Nicolás, José M., Forns, Xavier, Plaza, Joan, Yagüe, Jordi, Sánchez-Tapias, Jose M., Font, Josep

“…To analyze the etiology, clinical presentation, and outcomes of patients with life-threatening cryoglobulinemic vasculitis. We studied 209 consecutive patients…”
Get full text

Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C by Lens, Sabela, Calleja, Jose L, Campillo, Ana, Carrión, Jose A, Broquetas, Teresa, Perello, Christie, de la Revilla, Juan, Mariño, Zoe, Londoño, María-Carlota, Sánchez-Tapias, Jose M, Urbano-Ispizua, Álvaro, Forns, Xavier

“…Telaprevir and Boceprevir are the first direct acting antivirals approved for chronic hepatitis C in combination with peg-interferon alfa and ribavirin…”
Get full text

Response‐guided peg‐interferon plus ribavirin treatment duration in chronic hepatitis C: Meta‐analyses of randomized, controlled trials and implications for the future by Di Martino, Vincent, Richou, Carine, Cervoni, Jean‐Paul, Sanchez‐Tapias, Jose M., Jensen, Donald M., Mangia, Alessandra, Buti, Maria, Sheppard, Frances, Ferenci, Peter, Thévenot, Thierry

“…Response‐guided pegylated interferon (peg‐IFN) plus ribavirin (P/R) therapy trials on genotype (G)1 and G2/G3 hepatitis C virus–infected patients provide…”
Get full text

Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response by FERNANDEZ-RODRIGUEZ, Conrado M, ALONSO, Sonia, FERNANDEZ, Inmaculada, GARCIA-SAMANIEGO, Javier, FUENTE, Javier, SOLA, Ricard, MORENO-OTERO, Ricardo, PLANAS, Ramón, MARTINEZ, Stella M, FORNS, Xavier, SANCHEZ-TAPIAS, Jose M, RINCON, Diego, RODRIGUEZ-CARAVACA, Gil, BARCENA, Rafael, SERRA, Miguel A, ROMERO-GOMEZ, Manuel

“…Patients with hepatitis C virus (HCV) cirrhosis are difficult to treat and have a high risk of liver decompensation or hepatocellular carcinoma. We sought to…”
Get full text

Hepatitis C: who should you treat and how? by Sánchez Tapias, José M, Rodés, Juan

“…At present the treatment of hepatitis C virus infection (HCV) has improved because of combined treatment with interferon (IFN) and ribavirin. The association…”
Get more information

Expected developments in hepatology by Forns, Xavier, Sánchez Tapias, José M., Parés, Albert, Llovet, Josep M., Bruix, Jordi, Rodés, Juan

“…It is very difficult to predict new developments in hepatology so we have decided to analyse the most important issues related to three clinical conditions in…”
Get full text

Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C by Guilera, Magda, Forns, Xavier, Torras, Xavier, Enríquez, Jaime, Coll, Susana, Solà, Ricard, Morillas, Rosa, Planas, Ramón, Ampurdanès, Sergi, Soler, Marta, Costa, Josep, Sáiz, Juan C, Sánchez-Tapias, José M, Rodés, Juan

“…Background/Aims: Alpha interferon administration is quite disappointing as a single therapy in chronic hepatitis C. A brief course of corticosteroid therapy…”
Get full text

Epidemiology of hepatitis C virus infection by Bruguera, Miguel, Tapias, Jose M. Sánchez

Get full text

How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients by Brito-Zerón, Pilar, Gheitasi, Hoda, Retamozo, Soledad, Bové, Albert, Londoño, María, Sánchez-Tapias, Jose-Maria, Caballero, Miguel, Kostov, Belchin, Forns, Xavier, Kaveri, Srini V, Ramos-Casals, Manuel

“…We conducted a study to analyze how infection by hepatitis C virus (HCV) may influence the immunological serum pattern of patients with Sjögren syndrome (SS)…”
Get full text

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients by LAGUNO, Montserrat, MURILLAS, Javier, LEON, Agathe, LONCA, Montserrat, MILINKOVIC, Ana, GATELL, Josep M, MALLOLAS, Josep, BLANCO, José Luis, MARTINEZ, Esteban, MIQUEL, Rosa, SANCHEZ-TAPIAS, José Ma, BARGALLO, Xavier, GARCIA-CRIADO, Angeles, DE LAZZARI, Elisa, LARROUSSE, Maria

“…Current therapies for chronic hepatitis C virus (HCV) in HIV co-infected patients have a low success rate and are poorly tolerated. We have evaluated the…”
Get full text

Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon by Gambato, Martina, Caro-Pérez, Noelia, González, Patricia, Cañete, Nuria, Mariño, Zoe, Lens, Sabela, Bonacci, Martín, Bartres, Concepció, Sánchez-Tapias, José-María, Carrión, José A, Forns, Xavier, Juan, Manel, Pérez-Del-Pulgar, Sofía, Londoño, María-Carlota

“…Real-life data showed an increased incidence of bacterial infections in patients with advanced liver disease receiving a protease inhibitor (PI)-containing…”
Get full text

Randomized trial comparing pegylated interferon α‐2b versus pegylated interferon α‐2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients by Laguno, Montserrat, Cifuentes, Carmen, Murillas, Javier, Veloso, Sergio, Larrousse, Maria, Payeras, Antoni, Bonet, Lucia, Vidal, Francese, Milinkovic, Ana, Bassa, Antoni, Villalonga, Concha, Pérez, Iñaki, Tural, Cristina, Martínez‐Rebollar, Maria, Calvo, Marta, Blanco, Jose Luis, Martínez, Estaban, Sánchez‐Tapias, Jose M., Gatell, Jose M., Mallolas, Jose

“…Although two pegylated interferons (Peg‐IFN) are available to treat chronic hepatitis C virus (HCV) infection, no head‐to‐head comparative studies have been…”
Get full text

Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b interferon by López‐Labrador, Francesc‐Xavier, Ampurdanès, Sergi, Giménez‐Barcons, Mireia, Guilera, Magdalena, Costa, Josep, Jiménez de Anta, María Teresa, Sánchez‐Tapias, Jose M., Rodés, Juan, Sáiz, Juan‐Carlos

“…In patients with chronic hepatitis C, the influence of the genetic heterogeneity of the hepatitis C virus (HCV) on the progression of liver disease and on the…”
Get full text